Atlas Trials

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

Clinical trial NCT00081809 · COMPLETED

Trial details

NCT number
NCT00081809
Sponsor
Agenus Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, FollicularLymphoma, Small Lymphocytic
Start date
2000-03-01
Primary completion
2005-06-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.